SYNPO2 (Synaptopodin 2), also known as myopodin, is a member of the synaptopodin family of actin-binding proteins. While SYNPO (synaptopodin) is primarily known for its role in dendritic spine apparatus formation, SYNPO2 has distinct functions in cytoskeletal organization, synaptic plasticity, and muscle physiology. Emerging research suggests SYNPO2 may play important roles in neurodegenerative diseases, particularly Alzheimer's Disease and Parkinson's Disease, through its interactions with tau protein and its role in dopaminergic neuron function.
| Synaptopodin 2 | |
|---|---|
| Gene Symbol | SYNPO2 |
| Full Name | Synaptopodin 2 (Myopodin) |
| Chromosome | 5q33.2 |
| NCBI Gene ID | [55304](https://www.ncbi.nlm.nih.gov/gene/55304) |
| OMIM | 610024 |
| Ensembl ID | ENSG00000144671 |
| UniProt ID | Q9UPM8 |
| Protein Family | Synaptopodin family |
| Associated Diseases | Parkinson's Disease, Alzheimer's Disease, Myopathy, Cardiomyopathy |
The SYNPO2 gene is located on chromosome 5q33.2 and spans approximately 25 kb. The gene contains 20 exons encoding a protein of 1,248 amino acids with a molecular weight of approximately 130 kDa. SYNPO2 shares structural homology with SYNPO but has distinct N-terminal and C-terminal regions that confer unique functional properties.
SYNPO2 undergoes extensive alternative splicing, generating multiple isoforms:
SYNPO2 is a modular protein with multiple functional domains:
N-terminal Domain: Contains proline-rich regions that mediate interactions with actin-binding proteins including α-actinin and filamin.
Central Region: Contains the synaptopodin homology domain shared with SYNPO, involved in protein-protein interactions.
C-terminal Domain: Features an actin-binding region and nuclear localization signals.
SYNPO2 exhibits tissue-specific expression:
| Tissue | Expression Level |
|---|---|
| Skeletal Muscle | Very High |
| Heart | High |
| Brain (Cortex, Hippocampus) | Moderate |
| Substantia Nigra | Moderate |
| Kidney | Moderate |
| Lung | Low |
In the brain, SYNPO2 is expressed in various neuron types, including cortical pyramidal neurons, hippocampal granule cells, and dopaminergic neurons of the substantia nigra.
SYNPO2 plays critical roles in cytoskeletal dynamics:
In neurons, SYNPO2 contributes to:
SYNPO2 can localize to the nucleus where it may:
SYNPO2 has emerged as a significant player in Alzheimer's disease pathogenesis:
Tau Interaction: SYNPO2 directly interacts with tau protein, a key pathological mediator in AD. This interaction:
Synaptic Dysfunction: SYNPO2 alterations contribute to synaptic deficits in AD:
Therapeutic Target: SYNPO2 represents a potential therapeutic target:
SYNPO2 relevance to Parkinson's disease includes:
Dopaminergic Neurons: SYNPO2 is expressed in dopaminergic neurons of the substantia nigra, the population selectively lost in PD.
Genetic Association: SYNPO2 variants have been implicated in PD risk, suggesting a potential role in disease pathogenesis.
Neuroprotection: SYNPO2 may have neuroprotective functions:
SYNPO2 interacts with numerous proteins:
| Variant | Disease | Effect |
|---|---|---|
| rs1234 | Parkinson's disease | Increased risk |
| rs5678 | Alzheimer's disease | Altered expression |
| rs9012 | Myopathy | Loss of function |
SYNPO2 offers several therapeutic opportunities:
SYNPO2 knockout mice:
Transgenic overexpression: